MICHAEL MAJETIC: Open Payments
NPI 1629577119 · GOOSE CREEK, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,135 in 57 payments from 18 companies in 2025. Trend: 2023 $1,290 · 2024 $1,101 · 2025 $1,135
Food & beverage: $1,135
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $201 |
| AstraZeneca Pharmaceuticals LP | 7 | $176 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $109 |
| Novo Nordisk Inc | 6 | $106 |
| PFIZER INC. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| Kowa Pharmaceuticals America, Inc. | 3 | $52 |
| Dexcom, Inc. | 2 | $50 |
| Lilly USA, LLC | 3 | $48 |
Products named: BREZTRI, VRAYLAR, Kerendia, CAPLYTA, Ozempic, XIFAXAN, ZORYVE, FARXIGA.
Industry payments across SC — which companies pay providers there.
